$ARQT Arcutis Biotherapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Arcutis Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Arcutis Biotherapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Arcutis Biotherapeutics, Inc. for free.
IRS Number: 812974255
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ARQT
Company Address: 2945 TOWNSGATE ROAD SUITE 110 WESTLAKE VILLAGE 91361
Phone number: 805-418-5006
Former name: Arcutis, Inc., date of change: 2019-09-05
Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne on June 1, 2016 and is headquartered in Westlake Village, CA.
Arcutis Biotherapeutics, Inc. Insiders Active In Last 3 Months
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Curran Terrie | Director | 0 | 0 | Nov 04 2020 | 3 months ago | ||
| Lock Kenneth A. | Chief Commercial Officer | 21,863 | 0 | shares bought: 21,863 / shares sold: 0 | STRONG BUY | Oct 27 2020 | 3 months ago |
| OSBORNE DAVID W | Chief Technical Officer | 250,533 | 0 | shares bought: 9,000 / shares sold: -30,000 | STRONG SELL | Dec 16 2020 | 1 month ago |
| Smither John W | Chief Financial Officer | 26,698 | 0 | shares bought: 25,875 / shares sold: -7,000 | STRONG BUY | Dec 16 2020 | 1 month ago |
| Watanabe Todd Franklin | President and CEO | 569,928 | 0 | shares bought: 94,481 / shares sold: -6,000 | STRONG BUY | Jan 07 2021 | 11 days ago |
| Welgus Howard G. | Director | 183,118 | 0 | shares bought: 49,984 / shares sold: -13,800 | STRONG BUY | Jan 14 2021 | 4 days ago |
View all Arcutis Biotherapeutics, Inc. insiders.
Arcutis Biotherapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 14 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 0.58 | 1,222 | 709 | 24,440 | |
| Jan 14 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 0.58 | 1,222 | 709 | 183,118 | 181.9 K to 183.1 K (+0.67 %) |
| Jan 07 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | M | 1.68 | 3,000 | 5,042 | 155,492 | |
| Jan 07 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 30.00 | 3,000 | 90,000 | 566,928 | 569.9 K to 566.9 K (-0.53 %) |
| Jan 07 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Buy | M | 1.68 | 3,000 | 5,042 | 569,928 | 566.9 K to 569.9 K (+0.53 %) |
| Jan 06 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 1,809 | 3,040 | 29,153 | |
| Jan 06 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 391 | 657 | 13,276 | |
| Jan 06 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 27.82 | 2,200 | 61,215 | 181,896 | 184.1 K to 181.9 K (-1.20 %) |
| Jan 06 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 1,809 | 3,040 | 184,096 | 182.3 K to 184.1 K (+0.99 %) |
| Jan 06 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 391 | 657 | 182,287 | 181.9 K to 182.3 K (+0.21 %) |
| Dec 16 2020 | ARQT | Arcutis Biotherape ... | OSBORNE DAVID W | Chief Technical Off ... | Sell | S | 30.00 | 15,000 | 450,000 | 250,533 | 265.5 K to 250.5 K (-5.65 %) |
| Dec 16 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 1,500 | 2,521 | 47,982 | |
| Dec 16 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 3,750 | 112,500 | 94,965 | 98.7 K to 95 K (-3.80 %) |
| Dec 16 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 1,500 | 45,000 | 25,198 | 26.7 K to 25.2 K (-5.62 %) |
| Dec 16 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 1,500 | 2,521 | 26,698 | 25.2 K to 26.7 K (+5.95 %) |
View all Arcutis Biotherapeutics, Inc. insider transactions.